0001974158-24-000015.txt : 20240320 0001974158-24-000015.hdr.sgml : 20240320 20240320163700 ACCESSION NUMBER: 0001974158-24-000015 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Enliven Therapeutics, Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 24768269 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-647-8519 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: IMARA Inc. DATE OF NAME CHANGE: 20160419 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ballal Rahul D. CENTRAL INDEX KEY: 0001805097 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 144 1 primary_doc.xml 144 0001805097 XXXXXXXX LIVE 0001672619 Enliven Therapeutics, Inc. 001-39247 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519 Ballal Rahul D. Director Common Jefferies LLC

520 Madison Ave 4th Fl New York NY 10022

20000 350800.00 41200000 03/20/2024 Nasdaq Common 01/28/2022 Stock Options Grant Enliven Therapeutics, Inc. N 12316 01/28/2022 N/A Common 01/28/2022 Stock Option Grant Enliven Therapeutics, Inc. N 2052 01/28/2022 N/A Common 01/28/2022 Stock Options Grant Enliven Therapeutics, Inc. N 2053 01/28/2022 N/A Common 10/19/2018 Stock Option Grant Enliven Therapeutics, Inc. N 3579 10/19/2018 N/A Y All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 10/19/2023, and all representations regarding material non-public information were made as of the adoption of the plan. 03/20/2024 10/19/2023 Rahul Ballal